- Report
- February 2026
- 250 Pages
Global
From €4166EUR$4,490USD£3,475GBP
- Report
- November 2026
- 368 Pages
Global
From €5428EUR$5,850USD£4,528GBP
- Report
- September 2026
- 197 Pages
Global
From €3289EUR$3,545USD£2,744GBP
€3655EUR$3,939USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €2932EUR$3,160USD£2,446GBP
€3665EUR$3,950USD£3,057GBP
- Report
- July 2024
- 150 Pages
Global
From €4500EUR$4,850USD£3,754GBP
- Report
- May 2024
- 54 Pages
Global
From €2320EUR$2,500USD£1,935GBP
- Report
- July 2025
- 314 Pages
Global
From €4106EUR$4,425USD£3,425GBP
The Aortic Endograft market is a segment of the Cardiovascular Devices industry. It is composed of medical devices used to treat aortic aneurysms, a condition in which the aorta becomes weakened and enlarged. Endografts are inserted into the aorta through a catheter, and are designed to reduce the risk of rupture and provide long-term support. Endografts are typically made of a combination of fabric and metal, and are designed to be durable and flexible.
Endografts are used to treat a variety of aortic aneurysms, including thoracic, abdominal, and thoracoabdominal aneurysms. Endografts are also used to treat aortic dissections, a condition in which the inner layers of the aorta tear. Endografts are a minimally invasive alternative to open surgery, and can reduce recovery time and hospital stays.
The Aortic Endograft market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Medtronic, Cook Medical, W.L. Gore & Associates, and Endologix. Show Less Read more